Skip to main content
OpenTrials

Clinical trial condition

Nonalcoholic Steatohepatitis (NASH)

Explore clinical trials studying Nonalcoholic Steatohepatitis (NASH). Study availability and eligibility vary by location and protocol.

33 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Nonalcoholic Steatohepatitis (NASH) trial results

Recruiting

Study of ADI-PEG 20 Versus Placebo in Subjects With NASH

NCT05842512

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Ditmanson Medical Foundation Chiayi Christian Hospital；Chiayi Christian Hospital (CYCH) Chiayi City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital(KMUH) Kaohsiung, Taiwan
  • E-Da Hospital (EDH) Kaohsiung, Taiwan
  • Chang Gung Medical Foundation-Kaohsiung (CGMF-KS) Kaohsiung, Taiwan
View Trial Details
Completed

A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension

NCT04880031

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Central Research Associates Birmingham, Alabama, United States
  • Arizona Liver Health Chandler, Arizona, United States
  • Arizona Liver Health Peoria, Arizona, United States
  • Arizona Liver Health Tucson, Arizona, United States
View all 48 locations
View Trial Details
Completed

A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor

NCT06024408

Conditions
Digestive System Diseases, Fatty Liver, Genetic Risk Factor, +4 more
Locations
  • Chungbuk National University Hospital Cheongju-si, Chungcheong Buk-do, South Korea
  • CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Severance Hospital Seoul, South Korea
View Trial Details
Completed

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT02443116

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • NGM Clinical Study Site 922 Chandler, Arizona, United States
  • NGM Clinical Study Site 923 Tucson, Arizona, United States
  • NGM Clinical Study Site 924 Los Angeles, California, United States
  • NGM Clinical Study Site 901 San Diego, California, United States
View all 22 locations
View Trial Details
Completed

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

NCT05623189

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +9 more
Locations
  • The Institute for Liver Health (Arizona Liver Health) Chandler, Arizona, United States
  • Arizona Liver Health - Glendae Peoria, Arizona, United States
  • Adobe Clinical Research LLC Tucson, Arizona, United States
  • Aizona Liver Health Tucson, Arizona, United States
View all 45 locations
View Trial Details
Completed

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

NCT05117489

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Site 207 Chandler, Arizona, United States
  • Site 209 Tucson, Arizona, United States
  • Site 214 Panorama City, California, United States
  • Site 233 Santa Ana, California, United States
View Trial Details
Completed

A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

NCT05320146

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Site 207 Chandler, Arizona, United States
  • Site 209 Tucson, Arizona, United States
  • Site 214 Panorama City, California, United States
  • Site 233 Santa Ana, California, United States
View Trial Details

Related conditions